Current
$150.21B
5-Year Average
$202.11B
All-Time High
$350.66B
All-Time Low
$75.66B
Market cap daily chart for Pfizer (PFE)
Jun 16, 2021 – Jun 12, 2026 · 1,254 trading days
Market Cap growth chart for Pfizer (PFE) from 1985 to 2026
Latest: +6.1%
Market Cap history table for Pfizer (PFE) from 1985 to 2026
| 2026 | $150.21B | +6.1% | +$8.63B | ||
| 2025 | $141.58B | -6.4% | −$9.64B | ||
| 2024 | $151.22B | -8.0% | −$13.14B | ||
| 2023 | $164.36B | -44.0% | −$129.40B | ||
| 2022 | $293.76B | -12.8% | −$43.30B | ||
| 2021 | $337.06B | +62.6% | +$129.74B | ||
| 2020 | $207.31B | -1.6% | −$3.46B | ||
| 2019 | $210.77B | -14.8% | −$36.56B | ||
| 2018 | $247.33B | +18.9% | +$39.36B | ||
| 2017 | $207.97B | +9.7% | +$18.34B | ||
| 2016 | $189.64B | -1.0% | −$1.83B | ||
| 2015 | $191.46B | +0.9% | +$1.76B | ||
| 2014 | $189.70B | -5.3% | −$10.53B | ||
| 2013 | $200.23B | +12.2% | +$21.77B | ||
| 2012 | $178.47B | +10.6% | +$17.05B | ||
| 2011 | $161.41B | +20.4% | +$27.39B | ||
| 2010 | $134.03B | +10.4% | +$12.57B | ||
| 2009 | $121.46B | +7.2% | +$8.12B | ||
| 2008 | $113.33B | -24.2% | −$36.20B | ||
| 2007 | $149.54B | -16.3% | −$29.04B | ||
| 2006 | $178.58B | +9.0% | +$14.72B | ||
| 2005 | $163.86B | -15.6% | −$30.22B | ||
| 2004 | $194.08B | -20.5% | −$49.93B | ||
| 2003 | $244.01B | +34.9% | +$63.14B | ||
| 2002 | $180.86B | -24.7% | −$59.45B | ||
| 2001 | $240.32B | -13.5% | −$37.39B | ||
| 2000 | $277.71B | +43.0% | +$83.46B | ||
| 1999 | $194.25B | +24.9% | +$38.68B | ||
| 1998 | $155.57B | +67.1% | +$62.47B | ||
| 1997 | $93.10B | +84.1% | +$42.53B | ||
| 1996 | $50.58B | +34.7% | +$13.02B | ||
| 1995 | $37.56B | +65.6% | +$14.88B | ||
| 1994 | $22.68B | +7.6% | +$1.60B | ||
| 1993 | $21.08B | -9.3% | −$2.15B | ||
| 1992 | $23.23B | -12.8% | −$3.41B | ||
| 1991 | $26.64B | +118.9% | +$14.47B | ||
| 1990 | $12.17B | +4.0% | +$464.20M | ||
| 1989 | $11.71B | +22.7% | +$2.17B | ||
| 1988 | $9.54B | +27.7% | +$2.07B | ||
| 1987 | $7.47B | -24.9% | −$2.47B | ||
| 1986 | $9.94B | +20.0% | +$1.66B | ||
| 1985 | $8.28B | — | — |
- 2026$150.21B+6.1%
- 2025$141.58B-6.4%
- 2024$151.22B-8.0%
- 2023$164.36B-44.0%
- 2022$293.76B-12.8%
- 2021$337.06B+62.6%
- 2020$207.31B-1.6%
- 2019$210.77B-14.8%
- 2018$247.33B+18.9%
- 2017$207.97B+9.7%
- 2016$189.64B-1.0%
- 2015$191.46B+0.9%
- 2014$189.70B-5.3%
- 2013$200.23B+12.2%
- 2012$178.47B+10.6%
- 2011$161.41B+20.4%
- 2010$134.03B+10.4%
- 2009$121.46B+7.2%
- 2008$113.33B-24.2%
- 2007$149.54B-16.3%
- 2006$178.58B+9.0%
- 2005$163.86B-15.6%
- 2004$194.08B-20.5%
- 2003$244.01B+34.9%
- 2002$180.86B-24.7%
- 2001$240.32B-13.5%
- 2000$277.71B+43.0%
- 1999$194.25B+24.9%
- 1998$155.57B+67.1%
- 1997$93.10B+84.1%
- 1996$50.58B+34.7%
- 1995$37.56B+65.6%
- 1994$22.68B+7.6%
- 1993$21.08B-9.3%
- 1992$23.23B-12.8%
- 1991$26.64B+118.9%
- 1990$12.17B+4.0%
- 1989$11.71B+22.7%
- 1988$9.54B+27.7%
- 1987$7.47B-24.9%
- 1986$9.94B+20.0%
- 1985$8.28B—
Market Cap values are taken from Pfizer's reported income statements (share counts) and end-of-day prices (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Market Cap at Pfizer (PFE)
According to Pfizer's latest reported financial statements, the company's latest reported market cap is $154.97B. Market capitalization is the total dollar value of all outstanding shares — shares outstanding × stock price — and the standard measure of a company's equity value. On this page, historical market cap snaps filing-period share counts to closing prices on or before each statement date (not intraday tick data).
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2026's annual market cap for Pfizer (PFE) came in at $150.21B – grew 6.1% year-over-year.
Over 2021–2026 (5 years), Pfizer market cap expanded at a -14.9% compound annual rate, with a net decline across the window.
Pfizer market cap plunged from $337.06B in 2021 to $150.21B in 2026, a 55.4% drawdown.
2021 marks the peak market cap at $337.06B, with the historical low of $7.47B recorded in 1987.
Pfizer Market Cap by Year
Pfizer Market Cap 2026: $150.21B
2026's market cap for Pfizer came in at $150.21B, grew 6.1% from 2025.
Pfizer Market Cap 2025: $141.58B
Pfizer posted market cap of $141.58B in 2025, declined 6.4% below 2024.
Pfizer Market Cap 2024: $151.22B
In 2024, Pfizer reported market cap of $151.22B, declined 8.0% below 2023.
Pfizer Market Cap 2023: $164.36B
Pfizer market cap in 2023 was $164.36B, plunged 44.0% below 2022.
Pfizer Market Cap 2022: $293.76B
Pfizer market cap in 2022 was $293.76B.
See more financial history for Pfizer (PFE).
Sector peers by Market Cap
Healthcare peers of Pfizer (PFE), ranked by their latest market cap
| $1.07T | |
| $579.83B | |
| $391.50B | |
| $371.00B | |
| $294.03B | |
| $277.22B | |
| $194.99B | |
| $189.18B |
- $1.07T
- $579.83B
- $391.50B
- $371.00B
- $294.03B
- $277.22B
- $194.99B
- $189.18B
Frequently asked questions
Pfizer (PFE) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation